AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Niagen Bioscience, Inc. Director's Dealing 2016

Jun 22, 2016

Director's Dealing

Opens in your device viewer

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2016-06-20

Reporting Person: Rhonemus Troy Allen (N/A)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-20	Common Stock	P	5000	$3.80	Acquired	10000	Direct
2016-06-20	Common Stock	P	2800	$2.887	Acquired	12800	Indirect

F1: Includes 1,667 shares held by Toni A. Rhonemus IRA, the Reporting Person's spouse.

F2: Includes an aggregate of 4,467 shares held by Toni A. Rhonemus IRA, the Reporting Person's spouse.

F3: Such purchase was made by Toni A. Rhonemus IRA, and is thus beneficially owned by the Reporting Person.